Thursday market watch

QLT PhotoTherapeutics (QLTI; TSE:QLT) was up $2.75 to $59.625 on Thursday following Wednesday's FDA approval of its Visudyne verteporfin photodynamic therapy to treat wet age-related macular degenerat...